Last updated: May 29, 2026

Application No. 18/207,246

SYSTEMS AND METHODS FOR ASSESSING DISEASE BURDEN AND PROGRESSION

Non-Final OA

Filed

Jun 08, 2023

Priority

Jun 08, 2022 — provisional 63/350,211 +2 more

Examiner

TORRES, JOSE

Art Unit

2664

Tech Center

2600 — Communications

Assignee

Progenics Pharmaceuticals Inc.

OA Round

1 (Non-Final)

Interview Optional

— +12.2% interview lift. Interview lift (+12.2%) is below the 15.0% threshold. A written response is recommended.

Based on 640 resolved cases, 2023–2026

Examiner Intelligence

TORRES, JOSE View full profile →

Grants 82% — above average

Career Allowance Rate

524 granted / 640 resolved

+19.9% vs TC avg

Moderate +12% lift

Without

With

+12.2%

Interview Lift

resolved cases with interview

Typical timeline

3y 0m

Avg Prosecution

14 currently pending

Career history

665

Total Applications

across all art units

Statute-Specific Performance

§101

2.7%

-37.3% vs TC avg

§103

66.7%

+26.7% vs TC avg

§102

14.1%

-25.9% vs TC avg

§112

11.8%

-28.2% vs TC avg

Black line = Tech Center average estimate • Based on career data from 640 resolved cases

Prosecution Timeline

Jun 08, 2023

Application Filed

Sep 10, 2025

Non-Final Rejection mailed

Jan 12, 2026

Response Filed

Precedent Cases

Applications granted by this same examiner with similar technology

18/519,619

Patent 12639805

METHOD TO AUTOMATE GAS LEAK DETECTION IN BATTERY MANUFACTURING USING DATA FROM OPTICAL GAS IMAGING SYSTEM

2y 6m to grant Granted May 26, 2026

18/603,550

Patent 12639822

DEEP LEARNING BASED IMAGE SEGMENTATION METHOD INCLUDING BIODEGRADABLE STENT IN INTRAVASCULAR OPTICAL TOMOGRAPHY IMAGE

2y 2m to grant Granted May 26, 2026

18/332,762

Patent 12633396

DOCUMENT CREATION SUPPORT APPARATUS, DOCUMENT CREATION SUPPORT METHOD, AND PROGRAM

2y 11m to grant Granted May 19, 2026

18/337,968

Patent 12632965

UNCERTAINTY ESTIMATION VIA OBJECT-SPECIFIC AND OBJECT-AGNOSTIC SEGMENTATION DISAGREEMENT

2y 11m to grant Granted May 19, 2026

18/339,193

Patent 12632964

SEQUENTIAL CONVOLUTIONAL NEURAL NETWORKS FOR NUCLEI SEGMENTATION

2y 11m to grant Granted May 19, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

82%

Grant Probability

94%

With Interview (+12.2%)

3y 0m (~0m remaining)

Median Time to Grant

Low

PTA Risk

Based on 640 resolved cases by this examiner. Grant probability derived from career allowance rate.

SYSTEMS AND METHODS FOR ASSESSING DISEASE BURDEN AND PROGRESSION

Interview Optional

Examiner Intelligence

Statute-Specific Performance

Prosecution Timeline

Precedent Cases

Applications granted by this same examiner with similar technology

Strategy Recommendation AI-generated — please review before filing

Prosecution Projections

Ready to respond to this office action?

Sign in with your work email